pI: 9.659 |
Length (AA): 141 |
MW (Da): 16064 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 139 | 1h3q (A) | 3 | 139 | 12.00 | 0 | 0.92 | 1.18 | -1.45 |
5 | 141 | 1h3q (A) | 4 | 140 | 14.00 | 0.0000000071 | 0.8 | 1.2 | -1.22 |
1 | 136 | 3cue (C) | 1 | 155 | 23.00 | 0 | 0.81 | 1.18144 | -0.69 |
2 | 141 | 2j3t (C) | 2 | 141 | 24.00 | 0 | 1 | 1.38741 | -1.14 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128429)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G51160 | Sybindin-like domain-containing protein |
Babesia bovis | BBOV_IV010580 | hypothetical protein |
Brugia malayi | Bm1_13955 | trafficking protein particle complex subunit 1, putative |
Candida albicans | CaO19.7934 | part of TRAPP (Transport Protein Particle) G890 |
Candida albicans | CaO19.302 | part of TRAPP (Transport Protein Particle) G890 |
Caenorhabditis elegans | CELE_DC2.8 | Protein DC2.8 |
Dictyostelium discoideum | DDB_G0273579 | hypothetical protein |
Dictyostelium discoideum | DDB_G0273467 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1359 | BET5 ortholog (S. cerevisiae) |
Echinococcus granulosus | EgrG_000828500 | Sybindin protein |
Entamoeba histolytica | EHI_197660 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000828500 | Sybindin protein |
Giardia lamblia | GL50803_95269 | Bet5-like protein |
Homo sapiens | ENSG00000170043 | trafficking protein particle complex 1 |
Leishmania braziliensis | LbrM.34.2790 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_352930.1 | Sybindin-like family, putative |
Leishmania infantum | LinJ.35.2930 | hypothetical protein, conserved |
Leishmania major | LmjF.35.2880 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.2880 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_14191 | hypothetical protein |
Mus musculus | ENSMUSG00000049299 | trafficking protein particle complex 1 |
Neospora caninum | NCLIV_065150 | sybindin-like family domain-containing protein, putative |
Oryza sativa | 4323988 | Os01g0513700 |
Plasmodium berghei | PBANKA_1037000 | trafficking protein particle complex subunit 1, putative |
Plasmodium falciparum | PF3D7_1405200 | trafficking protein particle complex subunit 1, putative |
Plasmodium knowlesi | PKNH_1352900 | trafficking protein particle complex subunit 1, putative |
Plasmodium vivax | PVX_086175 | trafficking protein particle complex subunit 1, putative |
Plasmodium yoelii | PY07060 | unknown protein |
Saccharomyces cerevisiae | YML077W | Bet5p |
Schistosoma mansoni | Smp_041680 | bet5-related |
Schmidtea mediterranea | mk4.006225.03 | Trafficking protein particle complex subunit 1 |
Schmidtea mediterranea | mk4.023587.01 | Trafficking protein particle complex subunit 1 |
Trypanosoma brucei gambiense | Tbg972.9.7910 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.9.12870 | trafficking protein particle complex subunit 1, putative |
Trypanosoma congolense | TcIL3000_9_5370 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.510659.74 | Sybindin-like family, putative |
Trypanosoma cruzi | TcCLB.510745.30 | Sybindin-like family, putative |
Toxoplasma gondii | TGME49_247648 | Sybindin family protein |
Trichomonas vaginalis | TVAG_001870 | bet5, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.3810 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.3810 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.3810 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.3810 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YML077W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_247648 | Toxoplasma gondii | Probably essential | sidik |
TGME49_247648 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.